# Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

> **NCT04263922** · PHASE4 · RECRUITING · sponsor: **The First Affiliated Hospital of Dalian Medical University** · enrollment: 466 (estimated)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Huaiqihuang granules
- **DRUG:** Valsartan capsule

## Key facts

- **NCT ID:** NCT04263922
- **Lead sponsor:** The First Affiliated Hospital of Dalian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-30
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-03-30
- **Target enrollment:** 466 (ESTIMATED)
- **Last updated:** 2024-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263922, "Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04263922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*